Survey of Vitamin and Mineral Supplementation after Gastric Bypass and Biliopancreatic Diversion for Morbid Obesity

被引:0
作者
Robert E Brolin
Michael Leung
机构
来源
Obesity Surgery | 1999年 / 9卷
关键词
Morbid obesity; postoperative care; gastric bypass; biliopancreatic diversion; vitamins; minerals; deficiency;
D O I
暂无
中图分类号
学科分类号
摘要
Background: The authors investigated whether practice patterns of bariatric surgeons correlate with published data regarding metabolic deficiencies after Roux-en-Y gastric bypass (RYGB) and biliopancreatic diversion (BPD). Methods: 109 surgeons completed a questionnaire to determine use of supplements and frequency of lab tests. Results: Regarding supplements routinely prescribed after RYGB, 96% of surgeons gave multivitamins, 63% gave iron, and 49% gave vitamin B12. After BPD, 96% of surgeons gave multivitamins, 67% gave iron, 42% gave vitamin B12, 97% gave calcium, 63% gave fat-soluble vitamins, and 21% gave protein supplements. Regarding laboratory tests obtained routinely after RYGB, 95% of surgeons do complete blood counts, 56% do iron determinations, 66% do vitamin B12 determinations, 58% do folate determinations, 76% do electrolyte determinations, and 8% test for proteins. After BPD, 96% of surgeons do complete blood counts, 80% do iron determinations, 67% do vitamin B12 determinations, 71% do folate determinations, 88% do electrolyte determinations, 84% do protein determinations, and 46% test for fat-soluble vitamins. Regarding frequency of blood tests, after RYGB, 22% of surgeons obtain them after 3 months, 33% after 6 months, and 41% after 12 months; 4% do not routinely obtain postoperative laboratory tests. After BPD, 46% of surgeons obtain them after 3 months, 33% after 6 months, and 16% after 12 months; one does not obtain laboratory tests. Surgeons estimated these deficiencies after RYGB: 16% iron, 12% vitamin B12, 14% anemia, 5% protein, and 3% calcium. They estimated these deficiencies after BPD: 26% iron, 11% vitamin B12, 21% anemia, 18% protein, 16% calcium, and 6% fat-soluble vitamins. The estimated incidence of deficiencies after RYGB was considerably lower than the published incidence. Unnecessary tests were commonly performed (electrolytes after RYGB). Conclusion: Despite wide variations in the performance of laboratory tests and the use of supplements, the practice patterns of most surgeons protect patients from developing severe metabolic deficiencies after RYGB and BPD.
引用
收藏
页码:150 / 154
页数:4
相关论文
共 50 条
  • [21] Botulinum toxin for chronic anal fissure after biliopancreatic diversion for morbid obesity
    Vanella, Serafino
    Brisinda, Giuseppe
    Marniga, Gaia
    Crocco, Anna
    Bianco, Giuseppe
    Maria, Giorgio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (10) : 1021 - 1027
  • [22] Parathyroid hormone and bone marker levels in patients with morbid obesity before and after biliopancreatic diversion
    Moreiro, J.
    Ruiz, O.
    Perez, G.
    Salinas, R.
    Urgeles, J. R.
    Riesco, M.
    Garcia-Sanz, M.
    OBESITY SURGERY, 2007, 17 (03) : 348 - 354
  • [23] Botulinum toxin for chronic anal fissure after biliopancreatic diversion for morbid obesity
    Serafino Vanella
    Giuseppe Brisinda
    Gaia Marniga
    Anna Crocco
    Giuseppe Bianco
    Giorgio Maria
    World Journal of Gastroenterology, 2012, (10) : 1021 - 1027
  • [24] Comparison of nutritional deficiencies after Roux-en-Y gastric bypass and after biliopancreatic diversion with Roux-en-Y gastric bypass
    Skroubis, G
    Sakellaropoulos, G
    Pouggouras, K
    Mead, N
    Nikiforidis, G
    Kalfarentzos, F
    OBESITY SURGERY, 2002, 12 (04) : 551 - 558
  • [25] Parathyroid Hormone and Bone Marker Levels in Patients with Morbid Obesity Before and After Biliopancreatic Diversion
    J. Moreiro
    O. Ruiz
    G. Perez
    R. Salinas
    J. R. Urgeles
    M. Riesco
    M. García-Sanz
    Obesity Surgery, 2007, 17
  • [26] Liver transplantation in a case of steatohepatitis and subacute hepatic failure after biliopancreatic diversion for morbid obesity
    Castillo, J
    Fábrega, E
    Escalante, CF
    Sanjuan, JCR
    Herrera, L
    Hernánz, F
    Martino, E
    Casafont, F
    Fleitas, MG
    OBESITY SURGERY, 2001, 11 (05) : 640 - 642
  • [27] Biliopancreatic diversion with duodenal switch vs. gastric bypass for severe obesity
    Herron, DM
    JOURNAL OF GASTROINTESTINAL SURGERY, 2004, 8 (04) : 406 - 407
  • [28] Biliopancreatic diversion for treatment of morbid obesity:: Experience in 180 consecutive cases
    Totté, E
    Hendrickx, L
    van Hee, R
    OBESITY SURGERY, 1999, 9 (02) : 161 - 165
  • [29] Biliopancreatic Diversion for Treatment of Morbid Obesity: Experience in 180 Consecutive Cases
    Erik Totté
    Leo Hendrickx
    Robrecht van Hee
    Obesity Surgery, 1999, 9 : 161 - 165
  • [30] Biliopancreatic diversion with duodenal switch vs. gastric bypass for severe obesity
    Daniel M. Herron
    Journal of Gastrointestinal Surgery, 2004, 8 : 406 - 407